Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07173205 · ClinicalTrials.gov registry record · NA

Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit

A NA study of Depression and Cancer, sponsored by East Carolina University.

Recruiting
Registry status
NA
Development phase
208
Enrollment target
2
Study locations

NCT07173205: Recruiting NA study of Depression and Cancer, sponsored by East Carolina University.

NCT07173205 is a NA study of Depression and Cancer that is actively recruiting participants, run by East Carolina University. The registered enrollment target is 208 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07173205, a NA study of Depression and Cancer, is actively recruiting participants, sponsored by East Carolina University.

RECRUITING
Registry status
NA
Development phase
208 participants
Enrollment target
2
Study locations

Study Summary

Our team has developed a digital intervention that aims to help adolescent and young adult cancer survivors (AYAs) manage symptoms of depression. This tool includes one psychoeducation component and four components that are based on evidence-based interventions for depression. The goal of this study is to test which component or combination of components meaningfully contribute to improvements in depressive symptoms among AYAs.

Primary Outcome

The primary outcome for this study is change in depressive symptoms from Baseline to Week 6. In order to be considered for inclusion in the optimized intervention, intervention components must result in a 3-point decrease in T-score on the Patient-Reported Outcomes Measurement Information System (PROMIS)® Computer Adaptive Test (CAT) for depression between W0 and W6. T-scores have a range from 0 to 100, a mean of 50, and a standard deviation of 10. On this measure, higher scores indicate greater

Interventions

  • BEHAVIORAL AYA Survivors Coping and Emotional Needs Toolkit (ASCENT)

Study Locations (2)

North Carolina

  • East Carolina University - Greenville
  • Wake Forest University - Winston-Salem

Trial Details

FieldValue
Enrollment Target 208 participants
Start Date 2025-10-25
Est. Completion 2027-03
Phase NA
East Carolina University

58 total trials

What NCT07173205 shows while recruiting

NCT07173205 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (74% lower).

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which AYA Survivors Coping and Emotional Needs Toolkit (ASCENT) is the first listed.

NCT07173205 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07173205 about?

NCT07173205 is a clinical study titled "Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit". Our team has developed a digital intervention that aims to help adolescent and young adult cancer survivors (AYAs) manage symptoms of depression. This tool includes one psychoeducation component and four components that are based on evidence-based interventions for depression. The goal of this study...

What is the current status of trial NCT07173205?

This trial is currently recruiting. It is a NA study. The enrollment target is 208 participants. The study started on 2025-10-25. Estimated completion is 2027-03.

What conditions does trial NCT07173205 study?

This clinical trial studies the following conditions: Depression, Cancer, Adolescent, Adult, Young Adult.

What interventions are being tested in trial NCT07173205?

The interventions under investigation include: AYA Survivors Coping and Emotional Needs Toolkit (ASCENT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07173205?

This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07173205 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07173205's enrollment target sits among peer trials

208 205th of 679 higher than 475 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465774 · 208 participants

    Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions

  • NCT03803332 · 208 participants · NA

    A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel

  • NCT04732065 · 208 participants · Phase 1

    ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

  • NCT05293756 · 208 participants · NA

    OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT07173205, the US trial registry maintained by the National Library of Medicine. NCT07173205 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.